Purchase Order 75N91025P00014
Award Date
12/9/24
Potential Completion Date
12/8/25
Potential Value
$11K
Federal Agency
National Cancer Institute
Awardee
Bio-Rad Laboratories, Inc.
Ultimate Awardee
Bio-Rad Laboratories, Inc.
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a maintenance agreement on various laboratory equipment, valued at $30,087.45, awarded by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division. The contract has an ultimate completion date of March 31, 2025. Bio-Rad Laboratories, Inc. is the parent company of the prime contractor and has established significant Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with various federal agencies,...
This federal contract award is for a MAINTENANCE AGREEMENT between the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), and Bio-Rad Laboratories, Inc. The contract has a ceiling value of $10,783.00 and a completion date of December 31, 2025. It was awarded on January 1, 2025 as a Firm Fixed Price Purchase Order. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is the prime contractor and is a global...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The $10,188.00 contract is for a service agreement with a completion date of May 13, 2025. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is an experienced federal contractor that provides a variety of...
This federal contract award, with ID 75N91020P00251, is for a maintenance agreement between the National Cancer Institute and Bio-Rad Laboratories, Inc. The $20,112.02 firm fixed-price contract does not have a set-aside designation. The contract was awarded on February 18, 2020 with an ultimate completion date of April 5, 2025. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics. The company has established...
This federal contract award, valued at $24,995.00, was issued by the National Cancer Institute (NCI) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. It does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a leading global manufacturer and supplier of specialized equipment, reagents, and consumables for life...
This federal contract award is to Bio-Rad Laboratories, Inc.'s Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract, valued at $1,133.06, was awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call, with a fixed price redetermination pricing type. The contract does not have a...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc. for the provision of various Bio-Rad real-time PCR systems. The contract has a total ceiling value of $11,685.88 and a completion date of December 31, 2024. Bio-Rad Laboratories is an experienced federal contractor, having previously provided specialized equipment, reagents, and services to various government agencies...
This is a $10,783.00 firm fixed-price service agreement awarded to Bio-Rad Laboratories, Inc., a global leader in scientific instrumentation and laboratory supplies, by the National Cancer Institute. The contract is for the delivery of unspecified products and services related to the agency's research activities, with a period of performance through April 2026. The contract is not set aside for small businesses. Bio-Rad Laboratories, Inc. holds a significant $1 billion blanket purchase agreement...
This is a $346,770.62 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is for the Laboratory of Receptor Biology and Gene Expression (LRGBE) to elucidate the mechanisms involved in the regulation of genetic expression in eukaryotic cells and identify the genes and regulatory processes involved in modulated states of expression. The...
This contract award to Bio-Rad Laboratories, Inc. Life Science Group Division is for $24,995.00 to provide laboratory equipment and supplies to the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The award is a Blanket Purchase Agreement (BPA) call contract with a firm fixed price pricing type. This contract is not set aside for any specific business category. Bio-Rad Laboratories, Inc. is a leading manufacturer and supplier of specialized equipment,...